EyePoint Pharmaceuticals, Inc. (EYPT) financial statements (2021 and earlier)

Company profile

Business Address 480 PLEASANT STREET
WATERTOWN, MA 02472
State of Incorp. DE
Fiscal Year End December 31
SIC 3826 - Laboratory Analytical Instruments (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
6/30/2018
6/30/2017
6/30/2016
6/30/2015
6/30/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments45223917292918
Cash and cash equivalents45223917151915
Short-term investments    1493
Receivables0      
Inventory, net of allowances, customer advances and progress billings52    
Inventory52     
Other undisclosed current assets131711111
Total current assets:63424018303019
Noncurrent Assets
Operating lease, right-of-use asset33
Property, plant and equipment1000000
Intangible assets, net (including goodwill)2528310123
Intangible assets, net (excluding goodwill)2528310123
Restricted cash and investments0000000
Other undisclosed noncurrent assets   0000
Total noncurrent assets:2931321233
TOTAL ASSETS:92737219323223
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities131175543
Accounts payable5431110
Accrued liabilities8744432
Employee-related liabilities     11
Deferred revenue10
Debt 0     
Deferred revenue and credits 0000
Other liabilities1      
Other undisclosed current liabilities  15  (1)(1)
Total current liabilities:1512225532
Noncurrent Liabilities
Long-term debt and lease obligation405017    
Long-term debt, excluding current maturities384717    
Operating lease, liability23
Liabilities, other than long-term debt183210666
Deferred revenue and credits 0666
Deferred revenue16 
Other liabilities231    
Derivative instruments and hedges, liabilities  20    
Total noncurrent liabilities:5853380666
Total liabilities:73656051198
Stockholders' equity
Stockholders' equity attributable to parent1981213212315
Common stock0000000
Additional paid in capital528473375323312293291
Accumulated other comprehensive income1111111
Accumulated deficit(511)(465)(364)(311)(292)(271)(277)
Total stockholders' equity:1981213212315
TOTAL LIABILITIES AND EQUITY:92737219323223

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
6/30/2018
6/30/2017
6/30/2016
6/30/2015
6/30/2014
Revenue, net 82273
Gross profit:3420382273
Operating expenses(72)(68)(29)(26)(23)(20)(17)
Operating income (loss):(37)(48)(26)(19)(22)6(13)
Nonoperating income (expense)(8)(9)(26)0000
Investment income, nonoperating  (26)  00
Other nonoperating income (expense)010000(0)
Interest and debt expense(1)(4)(1)    
Income (loss) from continuing operations before equity method investments, income taxes:(46)(61)(53)(18)(22)6(13)
Other undisclosed income from continuing operations before income taxes14     
Income (loss) from continuing operations before income taxes:(45)(57)(53)(18)(22)6(13)
Income tax expense (benefit)    0(0)0
Net income (loss) available to common stockholders, diluted:(45)(57)(53)(18)(22)6(13)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
6/30/2018
6/30/2017
6/30/2016
6/30/2015
6/30/2014
Net income (loss):(45)(57)(53)(18)(22)6(13)
Other comprehensive income (loss)000(0)(0)(0)0
Comprehensive income (loss), net of tax, attributable to parent:(45)(57)(53)(19)(22)6(13)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: